OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 34 filers reported holding OCULAR THERAPEUTIX INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,809,000 | -15.1% | 574,555 | -30.3% | 0.00% | 0.0% |
| Q3 2016 | $5,664,000 | +47.5% | 824,426 | +6.3% | 0.00% | 0.0% |
| Q2 2016 | $3,839,000 | -43.5% | 775,611 | +10.2% | 0.00% | -50.0% |
| Q1 2016 | $6,798,000 | +4.6% | 703,729 | +1.5% | 0.00% | +100.0% |
| Q4 2015 | $6,497,000 | +17.7% | 693,409 | +76.7% | 0.00% | 0.0% |
| Q3 2015 | $5,518,000 | -24.0% | 392,453 | +13.6% | 0.00% | -50.0% |
| Q2 2015 | $7,262,000 | +6.7% | 345,336 | +113.0% | 0.00% | 0.0% |
| Q1 2015 | $6,806,000 | +83.5% | 162,100 | +2.8% | 0.00% | +100.0% |
| Q4 2014 | $3,710,000 | +75.1% | 157,739 | +11.4% | 0.00% | 0.0% |
| Q3 2014 | $2,119,000 | – | 141,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,944,761 | $23,898,000 | 100.00% |
| Opaleye Management Inc. | 5,974,800 | $24,019,000 | 10.83% |
| DELTEC ASSET MANAGEMENT LLC | 2,069,313 | $8,319,000 | 1.95% |
| Kamunting Street Capital Management, L.P. | 275,506 | $1,108,000 | 1.50% |
| Altium Capital Management LP | 695,000 | $2,794,000 | 1.12% |
| Endurant Capital Management LP | 760,228 | $3,056,000 | 1.07% |
| EMERALD ADVISERS, LLC | 1,465,702 | $5,892,000 | 0.30% |
| MSD Partners, L.P. | 1,016,302 | $4,086,000 | 0.25% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,044,732 | $4,200,000 | 0.24% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $781,000 | 0.11% |